Socioeconomic benefits of psoralen/ultraviolet therapy.
D000875:Anthralin / Q000627:therapeutic use; D004185:Disability Evaluation; D004341:Drug Evaluation; D005260:Female; D011564:Furocoumarins / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010778:Photochemotherapy / Q000191:economics*; D011565:Psoriasis / Q000188:drug therapy*; D014467:Ultraviolet Therapy; D014938:Work Capacity Evaluation
D011564:Furocoumarins; D000875:Anthralin